Biomarkers to guide treatment decisions antibiotics has been proposed as an effective way to increase the use of more appropriate antibiotics. As a biomarker, procalcitonin (PCT) has been found to have good specificity to distinguish bacterial from non-bacterial inflammation. Decisions regarding the use of antibiotics in complex individual patient and should be based on the pre-test probability of bacterial infection, the severity of the presentation and the results of serum PCT concentrations.
In the context of high pre-test probability for bacterial infections and / or high-risk patients with sepsis, PCT monitoring from time to time helps to track the resolution of the initial infection and the decision about stopping of antibiotic treatment. As outlined by the Evidence-Based Medicine Laboratory (EBLM), not only pre-test probability but also the effect of the positive likelihood ratio test performance truly diagnostic. This aspect should be taken into account in the interpretation of results of clinical trials evaluating the performance of the PCT to guide antibiotic therapy.
modern clinical laboratories must confirm that the procedures used for certain tests that are reliable and valid. There are several sources of error and disturbance can undo the results. medical validation refers to check the plausibility of the results of the test. Results unreasonable indicate that something is wrong with the power of a sample taken from the patient, for example, a blood sample gets contaminated with other liquids, which require re-examination. Here, we describe how a business intelligence (BI) tools can be developed based on an integrated R that improve the efficiency of medical validation at the Institute of Clinical Chemistry (ICC) of the University Hospital Zurich. A BI software environment enables us to digitalize the steps in the manual validation process conducted in an Excel spreadsheet, for example, importing data, calculating percentiles, and produce graphical output.
Metatranscriptomics as a tool to identify fungal species and subspecies in mixed communities – proof of concept in the laboratory conditions.
High-throughput sequencing (HTS) allows the generation of large amounts of genome sequence data at a reasonable cost. Organisms within the microbial community mix can now be sorted and identified by culture-independent manner, typically using amplicon sequencing of DNA barcodes. Bulk RNA-seq (metatranscriptomics) has several advantages compared to amplicon-based DNA sequencing: less susceptible to bias amplification, it captures only living organism, and it enables a larger set of genes to be used for taxonomic identification. Using a mock society model comprising 17 fungal isolates, we evaluated whether metatranscriptomics can accurately identify fungal species and subspecies in mixed communities.
Overall, 72.9% of the RNA transcripts are classified, of which the majority (99.5%) were correctly identified at the species level. Of the 15 species of sequencing, 13 were captured and identified properly. We also detected strain-level variation in complex Cryptococcus species: 99.3% of the transcripts assigned to Cryptococcus classified as one of the four strains used in the community pretending. laboratory contaminants and / or misclassifications diverse, but only represents 0.44% of the transcripts.
Recombinant Hydra vulgaris Hydramacin-1 |
|||
MBS1049209-002mgYeast | MyBiosource | 0.02mg(Yeast) | 740 EUR |
Recombinant Hydra vulgaris Hydramacin-1 |
|||
MBS1049209-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 650 EUR |
Recombinant Hydra vulgaris Hydramacin-1 |
|||
MBS1049209-01mgYeast | MyBiosource | 0.1mg(Yeast) | 860 EUR |
Recombinant Hydra vulgaris Hydralysin (Hln) |
|||
MBS1393758-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1125 EUR |
Recombinant Hydra vulgaris Hydralysin (Hln) |
|||
MBS1393758-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 755 EUR |
Recombinant Hydra vulgaris Hydralysin (Hln) |
|||
MBS1393758-002mgYeast | MyBiosource | 0.02mg(Yeast) | 915 EUR |
Recombinant Hydra vulgaris Hydralysin (Hln) |
|||
MBS1393758-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 905 EUR |
Recombinant Hydra vulgaris Hydralysin (Hln) |
|||
MBS1393758-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1070 EUR |
Recombinant Hydra vulgaris Pedin |
|||
MBS1149522-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 875 EUR |
Recombinant Hydra vulgaris Pedin |
|||
MBS1149522-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 490 EUR |
Recombinant Hydra vulgaris Pedin |
|||
MBS1149522-005mgYeast | MyBiosource | 0.05mg(Yeast) | 695 EUR |
Recombinant Hydra vulgaris Pedin |
|||
MBS1149522-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 640 EUR |
Recombinant Hydra vulgaris Pedin |
|||
MBS1149522-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 700 EUR |
Recombinant Hydra vulgaris Pedibin |
|||
MBS1148200-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 880 EUR |
Recombinant Hydra vulgaris Pedibin |
|||
MBS1148200-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 500 EUR |
Recombinant Hydra vulgaris Pedibin |
|||
MBS1148200-005mgYeast | MyBiosource | 0.05mg(Yeast) | 700 EUR |
Recombinant Hydra vulgaris Pedibin |
|||
MBS1148200-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 655 EUR |
Recombinant Hydra vulgaris Pedibin |
|||
MBS1148200-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 700 EUR |
Recombinant Hydra vulgaris Antistasin |
|||
MBS1248250-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1120 EUR |
Recombinant Hydra vulgaris Antistasin |
|||
MBS1248250-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 700 EUR |
Recombinant Hydra vulgaris Antistasin |
|||
MBS1248250-002mgYeast | MyBiosource | 0.02mg(Yeast) | 875 EUR |
Recombinant Hydra vulgaris Antistasin |
|||
MBS1248250-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 840 EUR |
Recombinant Hydra vulgaris Antistasin |
|||
MBS1248250-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1020 EUR |
Recombinant Hydra vulgaris Endoglycoceramidase |
|||
MBS1353485-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1270 EUR |
Recombinant Hydra vulgaris Endoglycoceramidase |
|||
MBS1353485-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 1070 EUR |
Recombinant Hydra vulgaris Endoglycoceramidase |
|||
MBS1353485-005mgYeast | MyBiosource | 0.05mg(Yeast) | 1125 EUR |
Recombinant Hydra vulgaris Endoglycoceramidase |
|||
MBS1353485-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 1390 EUR |
Recombinant Hydra vulgaris Endoglycoceramidase |
|||
MBS1353485-02mgYeast | MyBiosource | 0.2mg(Yeast) | 1515 EUR |
Recombinant Hydra vulgaris Periculin-1 |
|||
MBS1388691-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1065 EUR |
Recombinant Hydra vulgaris Periculin-1 |
|||
MBS1388691-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 650 EUR |
Recombinant Hydra vulgaris Periculin-1 |
|||
MBS1388691-002mgYeast | MyBiosource | 0.02mg(Yeast) | 815 EUR |
Recombinant Hydra vulgaris Periculin-1 |
|||
MBS1388691-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 750 EUR |
Recombinant Hydra vulgaris Periculin-1 |
|||
MBS1388691-01mgYeast | MyBiosource | 0.1mg(Yeast) | 955 EUR |
Recombinant Hydra viridissima Hydralysin-1 (Hln-1) |
|||
MBS1447651-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1125 EUR |
Recombinant Hydra viridissima Hydralysin-1 (Hln-1) |
|||
MBS1447651-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 755 EUR |
Recombinant Hydra viridissima Hydralysin-1 (Hln-1) |
|||
MBS1447651-002mgYeast | MyBiosource | 0.02mg(Yeast) | 915 EUR |
Recombinant Hydra viridissima Hydralysin-1 (Hln-1) |
|||
MBS1447651-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 905 EUR |
Recombinant Hydra viridissima Hydralysin-1 (Hln-1) |
|||
MBS1447651-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1070 EUR |
Recombinant Hydra viridissima Hydralysin-2 (Hln-2) |
|||
MBS1450847-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1125 EUR |
Recombinant Hydra viridissima Hydralysin-2 (Hln-2) |
|||
MBS1450847-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 755 EUR |
Recombinant Hydra viridissima Hydralysin-2 (Hln-2) |
|||
MBS1450847-002mgYeast | MyBiosource | 0.02mg(Yeast) | 915 EUR |
Recombinant Hydra viridissima Hydralysin-2 (Hln-2) |
|||
MBS1450847-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 905 EUR |
Recombinant Hydra viridissima Hydralysin-2 (Hln-2) |
|||
MBS1450847-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1070 EUR |
Recombinant Hydra viridissima Hydralysin-3 (Hln-3) |
|||
MBS1383547-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1135 EUR |
Recombinant Hydra viridissima Hydralysin-3 (Hln-3) |
|||
MBS1383547-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 720 EUR |
Recombinant Hydra viridissima Hydralysin-3 (Hln-3) |
|||
MBS1383547-002mgYeast | MyBiosource | 0.02mg(Yeast) | 890 EUR |
Recombinant Hydra viridissima Hydralysin-3 (Hln-3) |
|||
MBS1383547-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 865 EUR |
Recombinant Hydra viridissima Hydralysin-3 (Hln-3) |
|||
MBS1383547-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1040 EUR |
Recombinant Hydra vulgaris Morphogenetic neuropeptide |
|||
MBS1011399-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 875 EUR |
Recombinant Hydra vulgaris Morphogenetic neuropeptide |
|||
MBS1011399-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 490 EUR |
Recombinant Hydra vulgaris Morphogenetic neuropeptide |
|||
MBS1011399-005mgYeast | MyBiosource | 0.05mg(Yeast) | 690 EUR |
Recombinant Hydra vulgaris Morphogenetic neuropeptide |
|||
MBS1011399-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 640 EUR |
Recombinant Hydra vulgaris Morphogenetic neuropeptide |
|||
MBS1011399-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 695 EUR |
Hydra-Sponge w/ Peptone Water - PK100 |
|||
FSA1172 | Scientific Laboratory Supplies | PK100 | 244.35 EUR |
Anti Hydra SP5 mouse monoclonal antibody |
|||
MBS157902-01mL | MyBiosource | 0.1mL | 350 EUR |
Anti Hydra SP5 mouse monoclonal antibody |
|||
MBS157902-5x01mL | MyBiosource | 5x0.1mL | 1250 EUR |
Recombinant Hydra vulgaris KS1 protein (KS1) |
|||
MBS1066916-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1120 EUR |
Recombinant Hydra vulgaris KS1 protein (KS1) |
|||
MBS1066916-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 700 EUR |
Recombinant Hydra vulgaris KS1 protein (KS1) |
|||
MBS1066916-002mgYeast | MyBiosource | 0.02mg(Yeast) | 875 EUR |
Recombinant Hydra vulgaris KS1 protein (KS1) |
|||
MBS1066916-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 840 EUR |
Recombinant Hydra vulgaris KS1 protein (KS1) |
|||
MBS1066916-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1020 EUR |
Recombinant Hydra vulgaris Annexin-B12 (ANXB12) |
|||
MBS1096630-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1195 EUR |
Recombinant Hydra vulgaris Annexin-B12 (ANXB12) |
|||
MBS1096630-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 845 EUR |
Recombinant Hydra vulgaris Annexin-B12 (ANXB12) |
|||
MBS1096630-002mgYeast | MyBiosource | 0.02mg(Yeast) | 985 EUR |
Recombinant Hydra vulgaris Annexin-B12 (ANXB12) |
|||
MBS1096630-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1015 EUR |
Recombinant Hydra vulgaris Annexin-B12 (ANXB12) |
|||
MBS1096630-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1120 EUR |
Recombinant Hydra vulgaris Tropomyosin-1 (TROP1) |
|||
MBS1144651-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1135 EUR |
Recombinant Hydra vulgaris Tropomyosin-1 (TROP1) |
|||
MBS1144651-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 765 EUR |
Recombinant Hydra vulgaris Tropomyosin-1 (TROP1) |
|||
MBS1144651-002mgYeast | MyBiosource | 0.02mg(Yeast) | 925 EUR |
Recombinant Hydra vulgaris Tropomyosin-1 (TROP1) |
|||
MBS1144651-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 920 EUR |
Recombinant Hydra vulgaris Tropomyosin-1 (TROP1) |
|||
MBS1144651-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1080 EUR |
Recombinant Hydra vulgaris Actin, non-muscle 6.2 |
|||
MBS1128576-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1250 EUR |
Recombinant Hydra vulgaris Actin, non-muscle 6.2 |
|||
MBS1128576-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 915 EUR |
Recombinant Hydra vulgaris Actin, non-muscle 6.2 |
|||
MBS1128576-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1040 EUR |
Recombinant Hydra vulgaris Actin, non-muscle 6.2 |
|||
MBS1128576-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1100 EUR |
Recombinant Hydra vulgaris Actin, non-muscle 6.2 |
|||
MBS1128576-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1185 EUR |
Recombinant Hydra vulgaris Laminin subunit beta-1 |
|||
MBS1355494-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1065 EUR |
Recombinant Hydra vulgaris Laminin subunit beta-1 |
|||
MBS1355494-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 650 EUR |
Recombinant Hydra vulgaris Laminin subunit beta-1 |
|||
MBS1355494-002mgYeast | MyBiosource | 0.02mg(Yeast) | 815 EUR |
Recombinant Hydra vulgaris Laminin subunit beta-1 |
|||
MBS1355494-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 755 EUR |
Recombinant Hydra vulgaris Laminin subunit beta-1 |
|||
MBS1355494-01mgYeast | MyBiosource | 0.1mg(Yeast) | 955 EUR |
Recombinant Hydra viridissima 40S ribosomal protein SA |
|||
MBS1043552-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1175 EUR |
Recombinant Hydra viridissima 40S ribosomal protein SA |
|||
MBS1043552-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 815 EUR |
Recombinant Hydra viridissima 40S ribosomal protein SA |
|||
MBS1043552-002mgYeast | MyBiosource | 0.02mg(Yeast) | 960 EUR |
Recombinant Hydra viridissima 40S ribosomal protein SA |
|||
MBS1043552-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 980 EUR |
Recombinant Hydra viridissima 40S ribosomal protein SA |
|||
MBS1043552-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1125 EUR |
Recombinant Hydra vulgaris Elongation factor 1-alpha |
|||
MBS1050397-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1335 EUR |
Recombinant Hydra vulgaris Elongation factor 1-alpha |
|||
MBS1050397-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 1030 EUR |
Recombinant Hydra vulgaris Elongation factor 1-alpha |
|||
MBS1050397-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1130 EUR |
Recombinant Hydra vulgaris Elongation factor 1-alpha |
|||
MBS1050397-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1200 EUR |
Recombinant Hydra vulgaris Elongation factor 1-alpha |
|||
MBS1050397-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1285 EUR |
Recombinant Hydra attenuata SP5 protein, N- His Tag |
|||
MBS157545-005mg | MyBiosource | 0.05mg | 320 EUR |
Recombinant Hydra attenuata SP5 protein, N- His Tag |
|||
MBS157545-01mg | MyBiosource | 0.1mg | 410 EUR |
Recombinant Hydra attenuata SP5 protein, N- His Tag |
|||
MBS157545-5x01mg | MyBiosource | 5x0.1mg | 1520 EUR |
Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1) |
|||
MBS1299441-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1225 EUR |
Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1) |
|||
MBS1299441-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 885 EUR |
Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1) |
|||
MBS1299441-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1015 EUR |
Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1) |
|||
MBS1299441-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1065 EUR |
Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1) |
|||
MBS1299441-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1160 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1) |
|||
MBS1188614-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1110 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1) |
|||
MBS1188614-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 690 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1) |
|||
MBS1188614-002mgYeast | MyBiosource | 0.02mg(Yeast) | 865 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1) |
|||
MBS1188614-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 830 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1) |
|||
MBS1188614-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1010 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2) |
|||
MBS1150542-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1110 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2) |
|||
MBS1150542-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 705 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2) |
|||
MBS1150542-002mgYeast | MyBiosource | 0.02mg(Yeast) | 860 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2) |
|||
MBS1150542-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 825 EUR |
Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2) |
|||
MBS1150542-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1010 EUR |
Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15) |
|||
MBS1148433-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1125 EUR |
Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15) |
|||
MBS1148433-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 705 EUR |
Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15) |
|||
MBS1148433-002mgYeast | MyBiosource | 0.02mg(Yeast) | 875 EUR |
Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15) |
|||
MBS1148433-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 845 EUR |
Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15) |
|||
MBS1148433-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1025 EUR |
Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B |
|||
MBS1068728-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1235 EUR |
Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B |
|||
MBS1068728-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 900 EUR |
Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B |
|||
MBS1068728-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1025 EUR |
Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B |
|||
MBS1068728-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1080 EUR |
Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B |
|||
MBS1068728-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1170 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-A |
|||
MBS1123045-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1290 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-A |
|||
MBS1123045-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 970 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-A |
|||
MBS1123045-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1085 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-A |
|||
MBS1123045-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1130 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-A |
|||
MBS1123045-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1230 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-B |
|||
MBS1261963-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1265 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-B |
|||
MBS1261963-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 935 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-B |
|||
MBS1261963-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1055 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-B |
|||
MBS1261963-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1125 EUR |
Recombinant Hydra viridissima G2/mitotic-specific cyclin-B |
|||
MBS1261963-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1200 EUR |
Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP) |
|||
MBS1030165-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1345 EUR |
Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP) |
|||
MBS1030165-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 1045 EUR |
Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP) |
|||
MBS1030165-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1140 EUR |
Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP) |
|||
MBS1030165-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1220 EUR |
Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP) |
|||
MBS1030165-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1300 EUR |
Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70) |
|||
MBS1203402-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1035 EUR |
Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70) |
|||
MBS1203402-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 610 EUR |
Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70) |
|||
MBS1203402-002mgYeast | MyBiosource | 0.02mg(Yeast) | 785 EUR |
Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70) |
|||
MBS1203402-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 710 EUR |
Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70) |
|||
MBS1203402-01mgYeast | MyBiosource | 0.1mg(Yeast) | 920 EUR |
EB Eraser |
|||
TD0006-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: EB Eraser |
|||
EB Eraser |
|||
TD0006-1g | TargetMol Chemicals | 1g | Ask for price |
Description: EB Eraser |
|||
EB Eraser |
|||
TD0006-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: EB Eraser |
|||
EB Eraser |
|||
TD0006-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: EB Eraser |
|||
EB Eraser |
|||
TD0006-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: EB Eraser |
|||
EB Eraser |
|||
MBS5786698-INQUIRE | MyBiosource | INQUIRE | Ask for price |
EB Eraser |
|||
MBS8579847-100Tests | MyBiosource | 100Tests | 195 EUR |
EB Eraser |
|||
MBS8579847-50Tests | MyBiosource | 50Tests | 160 EUR |
EB Eraser |
|||
MBS8579847-5x100Tests | MyBiosource | 5x100Tests | 835 EUR |
EB Eraser |
|||
MBS8579847-5x50Tests | MyBiosource | 5x50Tests | 665 EUR |
Recombinant Hydra vulgaris Myosin heavy chain, clone 203, partial |
|||
MBS1040747-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog |
|||
MBS1366985-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1105 EUR |
Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog |
|||
MBS1366985-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 695 EUR |
Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog |
|||
MBS1366985-002mgYeast | MyBiosource | 0.02mg(Yeast) | 855 EUR |
Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog |
|||
MBS1366985-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 815 EUR |
Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog |
|||
MBS1366985-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1005 EUR |
Recombinant Hydra vulgaris PC3-like endoprotease variant B, partial |
|||
MBS1168588-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hydra vulgaris Tyrosine-protein kinase STK (STK), partial |
|||
MBS1066436-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Therefore, these results show that it is possible to obtain an accurate species- and strain-level fungal identification of the data metatranscriptome during taxa identified at low abundance discarded to avoid false-positives that come from contamination or misclassifications. This study highlights both the benefits and challenges in the implementation metatranscriptomics currently in clinical mycology and ecology studies.